Patient
|
Primary tumor
|
Local vs. regional failure
|
Full coverage by CTV54
|
Marginal coverage by CTV54
|
Full coverage by CTV66
|
Marginal coverage by CTV66
|
Full coverage by CTV72
|
Marginal coverage by CTV72
|
Most probable explanation for relapse
|
---|
1
|
larynx
|
local
|
Yes
|
No
|
Yes
|
No
|
Yes
|
No
|
radioresistance
|
2
|
hypopharynx
|
local
|
Yes
|
No
|
NA
|
NA
|
No
|
Yes
|
underdosage
|
3
|
hypopharynx
|
local
|
Yes
|
No
|
Yes
|
No
|
Yes
|
No
|
radioresistance
|
4
|
larynx
|
local
|
Yes
|
No
|
Yes
|
No
|
No
|
Yes
|
underdosage
|
5
|
larynx
|
local
|
Yes
|
No
|
NA
|
NA
|
Yes
|
No
|
radioresistance
|
6
|
hypopharynx
|
regional
|
Yes
|
No
|
No
|
Yes
|
No
|
Yes
|
underdosage
|
7
|
larynx
|
local
|
Yes
|
No
|
NA
|
NA
|
Yes
|
No
|
radioresistance
|
8
|
larynx
|
local and regional
|
Yes
|
No
|
NA
|
NA
|
Yes
|
No
|
radioresistance
|
9
|
hypopharynx
|
local
|
Yes
|
No
|
No
|
Yes
|
No
|
Yes
|
underdosage
|
10
|
hypopharynx
|
local
|
Yes
|
No
|
Yes
|
No
|
Yes
|
No
|
radioresistance
|
-
Abbreviations:
CTV clinical target volume, CTV54 clinical target volume covered by 54Gy, CTV66 clinical target volume covered by 66Gy, CTV72 clinical target volume covered by 72Gy, NA non-applicable.